Your Article Summary
See Latest ArticlesEndocannabinoids and immune regulation
Pharmacological Research , 06/29/09
Pandey R et al. - Studies from the laboratory have suggested that administration of endocannabinoids or use of inhibitors of enzymes that breakdown the endocannabinoids, leads to immunosuppression and recovery from immune-mediated injury to organs such as the liver. Thus, manipulation of endocannabinoids in vivo may constitute a novel treatment modality against inflammatory disorders.
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II
Clinical Pharmacokinetics, 12/01/09
Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
British Journal of Clinical Pharmacology, 11/30/09
A Conserved Motif in the Membrane Proximal C-Terminal Tail of Human Muscarinic M1 Acetylcholine Receptors Affects Plasma Membrane Expression
Journal of Pharmacology and Experimental Therapeutics, 11/25/09